Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAI.

Yokogawa N, Kaneko T, Nagai Y, Nunokawa T, Sawaki T, Shiroto K, Shimada K, Sugii S.

Mod Rheumatol. 2015 Mar;25(2):264-9. doi: 10.3109/14397595.2014.948587. Epub 2014 Aug 26.

PMID:
25156777
2.

Long-term heat exposure prevents hypoxia-induced apoptosis in mouse fibroblast cells.

Sugimoto N, Shido O, Matsuzaki K, Katakura M, Hitomi Y, Tanaka M, Sawaki T, Fujita Y, Kawanami T, Masaki Y, Okazaki T, Nakamura H, Koizumi S, Yachie A, Umehara H.

Cell Biochem Biophys. 2014 Sep;70(1):301-7. doi: 10.1007/s12013-014-9912-9.

PMID:
24648161
3.

Upregulation of aquaporin expression in the salivary glands of heat-acclimated rats.

Sugimoto N, Matsuzaki K, Ishibashi H, Tanaka M, Sawaki T, Fujita Y, Kawanami T, Masaki Y, Okazaki T, Sekine J, Koizumi S, Yachie A, Umehara H, Shido O.

Sci Rep. 2013;3:1763. doi: 10.1038/srep01763.

4.

Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?

Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T, Miki M, Sakai T, Kawanami T, Sawaki T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H.

J Clin Exp Hematop. 2013;53(1):79-85.

5.

Complete photochromic structural changes in ruthenium(II)-diimine complexes, based on control of the excited states by metalation.

Sawaki T, Ishizuka T, Kawano M, Shiota Y, Yoshizawa K, Kojima T.

Chemistry. 2013 Jul 1;19(27):8978-90. doi: 10.1002/chem.201300437. Epub 2013 May 16.

PMID:
23681489
6.

Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.

Fukushima T, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Sawaki T, Fujita Y, Tanaka M, Masaki Y, Okazaki T, Nakajima H, Motoo Y, Umehara H.

Anticancer Res. 2012 Dec;32(12):5437-40.

PMID:
23225448
7.

Skewed production of IL-6 and TGFβ by cultured salivary gland epithelial cells from patients with Sjögren's syndrome.

Kawanami T, Sawaki T, Sakai T, Miki M, Iwao H, Nakajima A, Nakamura T, Sato T, Fujita Y, Tanaka M, Masaki Y, Fukushima T, Hirose Y, Taniguchi M, Sugimoto N, Okazaki T, Umehara H.

PLoS One. 2012;7(10):e45689. doi: 10.1371/journal.pone.0045689. Epub 2012 Oct 30.

8.

Cellular heat acclimation regulates cell growth, cell morphology, mitogen-activated protein kinase activation, and expression of aquaporins in mouse fibroblast cells.

Sugimoto N, Shido O, Matsuzaki K, Ohno-Shosaku T, Hitomi Y, Tanaka M, Sawaki T, Fujita Y, Kawanami T, Masaki Y, Okazaki T, Nakamura H, Koizumi S, Yachie A, Umehara H.

Cell Physiol Biochem. 2012;30(2):450-7. doi: 10.1159/000339038. Epub 2012 Jul 6.

9.

Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease.

Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, Nakada S, Matsui S, Origuchi T, Nishiyama S, Yamada K, Kawano M, Hirabayashi A, Fujikawa K, Sugiura T, Horikoshi M, Umeda N, Minato H, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Sawaki T, Kawanami T, Fujita Y, Tanaka M, Fukushima T, Eguchi K, Sugai S, Umehara H.

Int J Rheumatol. 2012;2012:580814. doi: 10.1155/2012/580814. Epub 2012 May 10.

10.

[Once-weekly bortezomib plus dexamethasone therapy induced complete response, reducing severe gastrointestinal adverse events for a patient with relapsed multiple myeloma - a case report].

Fukushima T, Iwao H, Sakai T, Sato T, Nakamura T, Nakajima A, Miki M, Sawaki T, Fujita Y, Tanaka M, Masaki Y, Umehara H.

Gan To Kagaku Ryoho. 2012 May;39(5):805-7. Japanese.

PMID:
22584336
11.

Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.

Fukushima T, Kawabata H, Sawaki T, Satoh T, Nakamura T, Iwao H, Nakajima A, Sakai T, Miki M, Fujita Y, Tanaka M, Kawanami T, Masaki Y, Okazaki T, Umehara H.

Anticancer Res. 2012 Apr;32(4):1347-53.

PMID:
22493369
12.

CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice.

Dong L, Watanabe K, Itoh M, Huan CR, Tong XP, Nakamura T, Miki M, Iwao H, Nakajima A, Sakai T, Kawanami T, Sawaki T, Masaki Y, Fukushima T, Fujita Y, Tanaka M, Yano M, Okazaki T, Umehara H.

Int Immunol. 2012 May;24(5):327-37. doi: 10.1093/intimm/dxs008. Epub 2012 Feb 17.

PMID:
22345277
13.

Prevention of fasting-mediated bone marrow atrophy by leptin administration.

Fujita Y, Yanagida H, Mimori T, Jin ZX, Sakai T, Kawanami T, Sawaki T, Masaki Y, Fukushima T, Okazaki T, Umehara H.

Cell Immunol. 2012;273(1):52-8. doi: 10.1016/j.cellimm.2011.11.007. Epub 2011 Dec 4.

PMID:
22196379
14.

Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events.

Fukushima T, Nakamura T, Iwao H, Nakajima A, Miki M, Sato T, Sakai T, Sawaki T, Fujita Y, Tanaka M, Masaki Y, Nakajima H, Motoo Y, Umehara H.

Anticancer Res. 2011 Jun;31(6):2297-302.

PMID:
21737655
15.

Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia.

Fukushima T, Kawabata H, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Sawaki T, Fujita Y, Tanaka M, Masaki Y, Hirose Y, Umehara H.

Anticancer Res. 2011 May;31(5):1741-4.

PMID:
21617233
16.

High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma.

Masaki Y, Miki M, Sun Y, Nakamura T, Iwao H, Nakajima A, Kurose N, Sakai T, Jin ZX, Sawaki T, Kawanami T, Fujita Y, Tanaka M, Fukushima T, Hirose Y, Umehara H.

Int J Hematol. 2011 Jun;93(6):720-726. doi: 10.1007/s12185-011-0848-1. Epub 2011 May 15.

PMID:
21573892
17.

Mechanistic insights into photochromic behavior of a ruthenium(II)-pterin complex.

Ishizuka T, Sawaki T, Miyazaki S, Kawano M, Shiota Y, Yoshizawa K, Fukuzumi S, Kojima T.

Chemistry. 2011 Jun 6;17(24):6652-62. doi: 10.1002/chem.201003522. Epub 2011 May 3. Erratum in: Chemistry. 2011 Aug 29;17(36):9858.

PMID:
21542034
18.

[Intravascular large B-cell lymphoma: an important cause of fever of unknown origin].

Masaki Y, Miki M, Sakai T, Sawaki T, Fukushima T, Umehara H.

Brain Nerve. 2011 May;63(5):435-41. Review. Japanese.

PMID:
21515922
19.

Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants.

Daniels TE, Cox D, Shiboski CH, Schiødt M, Wu A, Lanfranchi H, Umehara H, Zhao Y, Challacombe S, Lam MY, De Souza Y, Schiødt J, Holm H, Bisio PA, Gandolfo MS, Sawaki T, Li M, Zhang W, Varghese-Jacob B, Ibsen P, Keszler A, Kurose N, Nojima T, Odell E, Criswell LA, Jordan R, Greenspan JS; Sjögren's International Collaborative Clinical Alliance Research Groups.

Arthritis Rheum. 2011 Jul;63(7):2021-30. doi: 10.1002/art.30381.

20.

Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis.

Cao Y, Jin ZX, Tong XP, Yue S, Sakai T, Kawanami T, Sawaki T, Miki M, Iwao H, Nakajima A, Masaki Y, Fukushima Y, Fujita Y, Nakajima H, Okazaki T, Umehara H.

Anticancer Res. 2010 Oct;30(10):3911-7.

PMID:
21036702
21.

Complete response obtained by bortezomib plus dexamethasone in a patient with relapsed multiple myeloma with multiple plasmacytomas.

Fukushima T, Nakamura T, Miki M, Sakai T, Iwao H, Nakajima A, Sawaki T, Fujita Y, Tanaka M, Masaki Y, Hirose Y, Umehara H.

Anticancer Res. 2010 Sep;30(9):3791-4.

PMID:
20944171
22.

DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1--analysis of their binding with TGF-β superfamily proteins.

Tanaka M, Murakami K, Ozaki S, Imura Y, Tong XP, Watanabe T, Sawaki T, Kawanami T, Kawabata D, Fujii T, Usui T, Masaki Y, Fukushima T, Jin ZX, Umehara H, Mimori T.

FEBS J. 2010 Oct;277(20):4278-89. doi: 10.1111/j.1742-4658.2010.07816.x. Epub 2010 Sep 22.

23.

[Primary neurolymphomatosis of the cervical nerve root].

Miki M, Masaki Y, Nakamura T, Iwao H, Nakajima A, Sakai T, Sawaki T, Kawanami T, Kaito M, Kurose N, Fujita Y, Tanaka M, Fukushima T, Hirose Y, Umehara H.

Rinsho Ketsueki. 2010 Jul;51(7):564-7. Japanese.

PMID:
20693778
24.

Cisplatin augments FAS-mediated apoptosis through lipid rafts.

Huang CR, Jin ZX, Dong L, Tong XP, Yue S, Kawanami T, Sawaki T, Sakai T, Miki M, Iwao H, Nakajima A, Masaki Y, Fukushima Y, Tanaka M, Fujita Y, Nakajima H, Okazaki T, Umehara H.

Anticancer Res. 2010 Jun;30(6):2065-71.

PMID:
20651352
25.

[Very good partial response and long time to progression by short-term bortezomib plus dexamethasone therapy for a patient with relapsed and refractory multiple myeloma-a case report].

Fukushima T, Iwao H, Nakajima A, Miki M, Sakai T, Sawaki T, Tanaka M, Masaki Y, Hirose Y, Umehara H.

Gan To Kagaku Ryoho. 2009 Aug;36(8):1387-9. Japanese.

PMID:
19692786
26.

MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy.

Fukushima T, Iwao H, Nakazima A, Miki M, Sakai T, Sawaki T, Tanaka M, Masaki Y, Hirose Y, Umehara H.

Anticancer Res. 2009 Aug;29(8):3361-4.

27.

Intravascular large B cell lymphoma: proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition.

Masaki Y, Dong L, Nakajima A, Iwao H, Miki M, Kurose N, Kinoshita E, Nojima T, Sawaki T, Kawanami T, Tanaka M, Shimoyama K, Kim C, Fukutoku M, Kawabata H, Fukushima T, Hirose Y, Takiguchi T, Konda S, Sugai S, Umehara H.

Int J Hematol. 2009 Jun;89(5):600-10. doi: 10.1007/s12185-009-0304-7. Epub 2009 Apr 14.

PMID:
19363707
28.

[Sjögren's syndrome].

Umehara H, Sawaki T, Kawanami T, Masaki Y, Fukushima T.

Nihon Rinsho. 2009 Mar;67(3):511-6. Review. Japanese.

PMID:
19280925
29.

Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.

Jin ZX, Huang CR, Dong L, Goda S, Kawanami T, Sawaki T, Sakai T, Tong XP, Masaki Y, Fukushima T, Tanaka M, Mimori T, Tojo H, Bloom ET, Okazaki T, Umehara H.

Int Immunol. 2008 Nov;20(11):1427-37. doi: 10.1093/intimm/dxn100. Epub 2008 Sep 26.

PMID:
18820264
30.

Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.

Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, Takahashi H, Shinomura Y, Imai K, Saeki T, Azumi A, Nakada S, Sugiyama E, Matsui S, Origuchi T, Nishiyama S, Nishimori I, Nojima T, Yamada K, Kawano M, Zen Y, Kaneko M, Miyazaki K, Tsubota K, Eguchi K, Tomoda K, Sawaki T, Kawanami T, Tanaka M, Fukushima T, Sugai S, Umehara H.

Ann Rheum Dis. 2009 Aug;68(8):1310-5. doi: 10.1136/ard.2008.089169. Epub 2008 Aug 13.

PMID:
18701557
31.

Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.

Fukushima T, Dong L, Sakai T, Sawaki T, Miki M, Tanaka M, Masaki Y, Hirose Y, Kuwana M, Umehara H.

Lupus. 2008 Mar;17(3):210-4. doi: 10.1177/0961203307086032.

PMID:
18372362
32.

[Identification of human salivary stem cells from cultured labial minor salivary cells].

Kawanami T, Matsuzaki Y, Sawaki T, Sakai T, Jin ZX, Masaki Y, Fukushima T, Tanaka M, Umehara H.

Nihon Rinsho Meneki Gakkai Kaishi. 2007 Dec;30(6):455-60. Review.

33.

[Analysis of clinical significance of anti-cyclic citrullinated peptide antibody (anti-CCP antibody) in rheumatoid arthritis (RA)].

Shimoyama K, Ogawa N, Sakai T, Sawaki T, Kawanami T, Karasawa H, Masaki Y, Tanaka M, Fukushima T, Hirose Y, Umehara H.

Nihon Rinsho Meneki Gakkai Kaishi. 2007 Oct;30(5):408-13. Japanese.

34.

Clonality analysis of lymphoproliferative disorders in patients with Sjögren's syndrome.

Dong L, Masaki Y, Takegami T, Jin ZX, Huang CR, Fukushima T, Sawaki T, Kawanami T, Saeki T, Kitagawa K, Sugai S, Okazaki T, Hirose Y, Umehara H.

Clin Exp Immunol. 2007 Nov;150(2):279-84. Review.

35.

Asymmetric total synthesis of (-)-Linderol A.

Yamashita M, Yadav ND, Sawaki T, Takao I, Kawasaki I, Sugimoto Y, Miyatake A, Murai K, Takahara A, Kurume A, Ohta S.

J Org Chem. 2007 Jul 20;72(15):5697-703. Epub 2007 Jun 19.

PMID:
17579456
36.

Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen.

Dong L, Masaki Y, Takegami T, Kawanami T, Itoh K, Jin ZX, Huang CR, Tong XP, Fukushima T, Tanaka M, Sawaki T, Sakai T, Sugai S, Okazaki T, Hirose Y, Umehara H.

Int Immunol. 2007 Mar;19(3):331-6. Epub 2007 Jan 31.

PMID:
17272286
37.

Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8.

Kawabata H, Sawaki T, Kawanami T, Shimoyama K, Karasawa H, Fukushima T, Masaki Y, Ogawa N, Hirose Y, Ozaki K, Shimanaka K, Takase S, Ueno H, Umehara H.

Intern Med. 2006;45(22):1309-14. Epub 2006 Dec 15.

38.

A case of Mikulicz's disease complicated with interstitial nephritis successfully treated by high-dose corticosteroid.

Shimoyama K, Ogawa N, Sawaki T, Karasawa H, Masaki Y, Kawabata H, Fukushima T, Wano Y, Hirose Y, Umehara H.

Mod Rheumatol. 2006;16(3):176-82.

PMID:
16767558
39.

Fractalkine in rheumatoid arthritis and allied conditions.

Umehara H, Tanaka M, Sawaki T, Jin ZX, Huang CR, Dong L, Kawanami T, Karasawa H, Masaki Y, Fukushima T, Hirose Y, Okazaki T.

Mod Rheumatol. 2006;16(3):124-30. Review.

PMID:
16767549
40.

Urinary pseudouridine in patients with lymphoma: comparison with other clinical parameters.

Masaki Y, Itoh K, Sawaki T, Karasawa H, Kawanami T, Fukushima T, Kawabata H, Wano Y, Hirose Y, Suzuki T, Sugai S, Umehara H.

Clin Chim Acta. 2006 Sep;371(1-2):148-51. Epub 2006 Apr 27.

PMID:
16643879
41.

Near-infrared spectroscopic determination of salinity and internal pressure of fluid inclusions in minerals.

Kagi H, Kiyasu A, Akagi T, Nara M, Sawaki T.

Appl Spectrosc. 2006 Apr;60(4):430-6.

PMID:
16613640
42.

[Successful salvage therapy of continuous low-dose irinotecan for a patient with relapsed and refractory diffuse large B-cell lymphoma].

Masaki Y, Sawaki T, Shimoyama K, Karasawa H, Kawanami T, Fukushima T, Kawabata H, Ogawa N, Wano Y, Sugai S, Hirose Y, Umehara H.

Rinsho Ketsueki. 2005 Sep;46(9):1074-7. Japanese.

PMID:
16440768
43.

Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan.

Hirose Y, Masaki Y, Sawaki T, Shimoyama K, Karasawa H, Kawabata H, Fukushima T, Ogawa N, Wano Y, Umehara H.

Eur J Haematol. 2006 Feb;76(2):109-18.

PMID:
16405431
44.

[Successful treatment with etoposide by oral administration for recurrence of gastric diffuse large B-cell lymphoma after surgical resection--a case report].

Fukushima T, Sawaki T, Shimoyama K, Karasawa H, Masaki Y, Kawabata H, Ogawa N, Wano Y, Hirose Y, Sugai S, Sutoh H, Itoh H, Kojima Y.

Gan To Kagaku Ryoho. 2005 Feb;32(2):251-3. Japanese.

PMID:
15751644
45.

Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease.

Shimada K, Kawarabayashi T, Tanaka A, Fukuda D, Nakamura Y, Yoshiyama M, Takeuchi K, Sawaki T, Hosoda K, Yoshikawa J.

Diabetes Res Clin Pract. 2004 Sep;65(3):227-34.

PMID:
15331202
46.

Oolong tea increases metabolic rate and fat oxidation in men.

Rumpler W, Seale J, Clevidence B, Judd J, Wiley E, Yamamoto S, Komatsu T, Sawaki T, Ishikura Y, Hosoda K.

J Nutr. 2001 Nov;131(11):2848-52.

PMID:
11694607
47.

Post-mortem changes of connectin in chicken skeletal muscle.

Suzuki A, Sawaki T, Hosaka M, Ikarashi Y, Nonami Y.

Meat Sci. 1985;15(2):77-83. doi: 10.1016/0309-1740(85)90048-8.

PMID:
22056126

Supplemental Content

Loading ...
Support Center